SYNDROME OF INCREASED EPITHELIAL PERMEABILITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
Main Article Content
Abstract
Currently, the role of the syndrome of increased epithelial permeability of the mucous membrane of the gastrointestinal tract, primarily the intestine, as the main pathogenetic mechanism for the development of inflammatory diseases not only of the intestine, but also of other organs and systems, including rheumatological diseases, is being discussed. The integrity of the intestinal barrier was assessed using morphological examination of mucosal biopsies (CO) of various gastrointestinal tract sections, followed by staining with hematoxylin and eosin. Electron microscopy can be used to visualize the distances between epithelial cells and the width of intercellular spaces. he analysis of the conducted studies revealed significant morphological shifts in all the studied departments of the digestive tract in rheumatological diseases, which are expressed in an increase in infiltration of the stroma of intestinal villi by lymphocytes and plasma cells, expansion of microvessels, an increase in the number of interepithelial lymphocytes, an increase in intercellular gaps, loss of enterocytes connection with the basal with the basal membrane, which indicates the development of SPEP in this category of patients.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Sturgeon C., Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016; 4: e1251384.
Chang J., Leong R.W., Wasinger V.C. et al. Impaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healing. Gastroenterology. 2017; 153: 723–31.
Fukui H. Increased intestinal permeability and decreased barrier function: does it really influence the risk of inflammation? Inflamm Intest Dis. 2016; 1(3): 135–45 doi: 10.1159/000447252.
Paone P., Cani P.D. Mucus barrier, mucins and gut microbiota: the expected slimy partners? Gut. 2020;69(12):2232–2243. DOI: 10.1136/gutjnl-2020-322260.
Tawiah A., Cornick S., Moreau F., Gorman H., Kumar M., Tiwari S., Chadee K. High MUC2 mucin expression and misfolding induce cellular stress, reactive oxygen production, and apoptosis in goblet cells. Am. J. Pathol. 2018;188(6):1354– 1373. DOI: 10.1016/j.ajpath.2018.02.007
Wada M., Tamura A., Takahashi N., Tsukita S. Loss of claudins 2 and 15 from mice causes defects in paracellular Na + flow and nutrient transport in gut and leads to death from malnutrition. Gastroenterology. 2013;144(2):369–380. DOI: 10.1053/j.gastro.2012.10.035.
Graziani C., Talocco C., De Sire R. et al. Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities. Eur Rev Med Pharmacol Sci. 2019; 23(2): 795–810.
Turner J.R. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009; 11: 799–809.
Luettig J, Rosenthal R, Barmeyer C, Schulzke JD. Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation Tissue Barriers. 2015;3(1-2):e977176.
Anderson JM, Van Itallie CM. Physiology and function of the tight junction. Cold Spring Harb Perspect Biol. 2009;1(2):a002584.
Pessione E. Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows. Front Cell Infect Microbiol. 2012;2:86.
Kumar M, Nagpal R, Kumar R, et al. Cholesterol lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res. 2012:902917.
Al-Sadi R, Guo S, Ye D, et al. TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-kВ Pathway. Am J Pathol. 2016;186(5):1151- 65.
Cunningham KE, Turner JR. Myosin light chain kinase: pulling the strings of epithelial tight junction function. Annals of the New York Academy of Sciences. 2012;1258(1):34-42.
Gangwar R, Meena AS, Shukla PK, et al. Calcium-mediated oxidative stress: a common mechanism in tight junction disruption by different types of cellular stress. Biochemical Journal. 2017;474(5):731-49.
Al-Dasooqi N, Wardill HR, Gibson RJ. Gastrointestinal Mucositis: The Role of MMP-Tight Junction Interactions in Tissue Injury Pathol. Oncol. Res. 2014;20:485-91.
Wang L, Llorente C, Hartmann P, et al. Methods to determine intestinal permeability and bacterial translocation during liver disease. Journal of Immunological Methods. 2015;421:44- 53.
Konig M. The microbiome in autoimmune rheumatic disease. Best Pract Res Clin Rheumatol. 2020;34(1):101473. doi:10.1016/j. berh.2019.101473.
Gordeev A. V., Galushko E. A., Savushkina N. M., Lila A. M. Periodontitis - a harbinger of rheumatoid arthritis? Scientific and practical rheumatology. 2018;56 (5):613-21.
Radwan-Oczko M, Duś-Ilnicka I, Richards P, et al. Rheumatoid arthritis patients’ oral health and disease activity. Int J Rheum Dis. 2019;22(8):1538-43.
Horta-Baas G, Romero-Figueroa MDS, Montiel-Jarquín AJ, et al. Intestinal Dysbiosis and Rheumatoid Arthritis: A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis. J Immunol Res. 2017;2017:4835189.
Jenks K, Stebbings S, Burton J, et al. Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial. J Rheumatol. 2010;37(10):2118-25.
de la Visitación N, Robles-Vera I, Toral M, Duarte J. Protective Effects of Probiotic Consumption in Cardiovascular Disease in Systemic Lupus Erythematosus. Nutrients. 2019;11(11):2676.
Karateev A. E., Galushko E. A. Intestinal lesions in patients with spondyloarthritis. Scientific and practical rheumatology. 2015;53(2):190-9.